Magic mushroom therapy tested for cancer Patients' anxiety
NCT ID NCT07072728
Summary
This study is testing whether a therapy session using the psychedelic compound psilocybin (from 'magic mushrooms') can help reduce anxiety in people struggling to adjust to a cancer diagnosis. About 87 adults will receive one of three different doses of psilocybin during a guided therapy session, with their anxiety levels tracked for several months. The goal is to see if this approach is safe and effective for easing the significant emotional distress that can come with a serious illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Empax Centre
RECRUITINGLeederville, Western Australia, 6007, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mind Medicine Australia Clinic
RECRUITINGAbbotsford, Victoria, 3067, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Paratus Clinical Research Melbourne
RECRUITINGNorthcote, Victoria, 3070, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.